MedTrace Logo

The Effects of Omega-3 Fatty Acids in Renal Transplantation

NCT01744067 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2015-12-08

No results posted yet for this study

Summary

Omega-3 fatty acids are provided through dietary intake of fish and seafood. Several dietary supplements containing omega-3 fatty acids are also commercially available. Some studies have described beneficial effects from omega-3 fatty acids, among them are anti-inflammatory, anti-thrombotic, anti-atherosclerotic, anti-arrhythmic, anti-hypertensive and lipid-modulating effects. Other studies have not confirmed these findings. This study will investigate the effects of omega-3 fatty acids on renal function and cardiovascular risk markers in renal transplant recipients.

Conditions

  • Disorder Related to Renal Transplantation

Interventions

DRUG

Omega-3 fatty acids

2,7 g omega-3 fatty acids / day (1 capsule 3 times a day / oral administration)

DRUG

Placebo

Placebo capsules 3 times a day (oral administration)

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • Pronova BioPharma

    collaborator INDUSTRY

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Ivar A Eide, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01744067 on ClinicalTrials.gov